Download PDF
Thromb Haemost 1991; 66(06): 741
DOI: 10.1055/s-0038-1646497
Letter to the Editor
Schattauer GmbH Stuttgart

Prothrombin Fragment 1+2 and Intensity of Treatment with Oral Anticoagulants

P M Mannucci
A. Bianchi Bonomi, Hemophilia and Thrombosis Center and Institute of Internal Medicine, Milano, Italy
,
B Bottasso
A. Bianchi Bonomi, Hemophilia and Thrombosis Center and Institute of Internal Medicine, Milano, Italy
,
A Tripodi
A. Bianchi Bonomi, Hemophilia and Thrombosis Center and Institute of Internal Medicine, Milano, Italy
› Author Affiliations
Further Information

Publication History

Received 10 April 1991

Accepted 27 May 1991

Publication Date:
26 July 2018 (online)

Also available at
  PDF Download  Permissions and Reprints
 

  • References

  • 1 Pelzer H, Schwarz A, Stuber W. Determination of human prothrombin activation fragment 1+2 in plasma with an antibody against a synthetic peptide. Thromb Haemostas 1991; 65: 153-9
    PubMedSearch in Google Scholar
  • 2 Aronson DL, Stevan L, Ball AP, Franza Jr BR, Finlayson JS. Generation of the combined prothrombin activation peptide (F1.2) during the clotting of blood and plasma. J Clin Invest 1977; 60: 1410-8
    CrossrefPubMedSearch in Google Scholar
  • 3 Bauer KA, Rosenberg RD. The pathophysiology of the prethrombotie state in humans: insights gained from studies using markers of the hemostatic system activation. Blood 1987; 70: 343-50
    PubMedSearch in Google Scholar
  • 4 Teitel JM, Bauer KA, Lau HK, Rosenberg RD. Studies of the prothrombin activation pathway utilizing radioimmunoassays for the F2/F1+2 fragment and thrombin-antithrombin complex. Blood 1982; 59: 1086-97
    PubMedSearch in Google Scholar
  • 5 Conway EM, Bauer KA, Barzegar S, Rosenberg RD. Suppression of hemostatic system activation by oral anticoagulants in the blood of patients with thrombotic diatheses. J Clin Invest 1989; 80: 1535-44
    PubMedSearch in Google Scholar